Morgan Stanley Assumes Coverage on Becton, Dickinson and Co (BDX) with an Equalweight
More News related to BDX
- Becton Dickinson (BDX) Announces 10M Share Buyback
- Becton, Dickinson and Company (BDX) Boosts Qtr. Dividend by 15.8% to $0.33/Share
- BD Board Declares Dividend Increase and Authorizes Additional Share Repurchases
- Becton, Dickinson (BDX) Tops Q3 Views; Names New President and New CFO
- BD Announces Executive Appointments of President and Chief Financial Officer
More News related to New Coverage
- Raymond James Starts Millicom (MICC) at Strong Buy
- Stifel Nicolaus Starts City National (CYN) at Hold
- Stifel Nicolaus Starts eHealth (Nasdaq: HLTH) with a Buy
- Wasserman & Associates initiates coverage on American Physicians Service Group (AMPH) with a Buy
- Jesup & Lamont Initiates Coverage on AutoZone (AZO) with a Hold.
Morgan Stanley assumes coverage on Becton, Dickinson and Co (NYSE: BDX) with an Equalweight.
Becton, Dickinson and Company (BD), is a medical technology company engaged in the manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, life science researchers, clinical laboratories, industry and the general public.
Related Categories
New CoverageStocks Mentioned
+1.69Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
